CD163 and cervical carcinoma: Accordingly, a study with human cervical carcinoma lines showed that tumor-derived IL-6 and PGE2 were responsible for skewing monocyte differentiation toward a CD14+CD163+ M2-type phenotype, and that this was reversible upon co-incubation with Th1 cells (130).